Manufacturer of Controlled Substances; Notice of Registration

Justice Department; Drug Enforcement Administration · 2011

Read Manufacturer of Controlled Substances; Notice of Registration by Justice Department; Drug Enforcement Administration (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/uslaw-fr-2011-13204.txt.

Description

Notice published in the Federal Register on 2011-05-27 by Justice Department; Drug Enforcement Administration. Text from federalregister.gov (official edition: govinfo). [FR Doc No: 2011-13204] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated January 18, 2011, and published in the Federal Register on February 2, 2011, 76 FR 5829, AMRI Rensselaer, Inc., 33 Riverside Avenue, Rensselaer, New York 12144, made application by renewal to.

Catalog record

CREATORJustice Department; Drug Enforcement Administration
YEAR2011
COLLECTIONLAW
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSEPublic Domain
RIGHTSPUBLIC DOMAIN
SOURCEFederal Register

Source: https://www.federalregister.gov/documents/2011/05/27/2011-13204/manufacturer-of-controlled-substances-notice-of-registration

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Manufacturer of Controlled Substances; Notice of Registration
Citation: us:fr:2011-13204
Creator: Justice Department; Drug Enforcement Administration
Year: 2011
Source-URL: https://www.federalregister.gov/documents/2011/05/27/2011-13204/manufacturer-of-controlled-substances-notice-of-registration
Context: Notice published in the Federal Register on 2011-05-27 by Justice Department; Drug Enforcement Administration. Text from federalregister.gov (official edition: govinfo).

[FR Doc No: 2011-13204]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated January 18, 2011, and published in the Federal 
Register on February 2, 2011, 76 FR 5829, AMRI Rensselaer, Inc., 33 
Riverside Avenue, Rensselaer, New York 12144, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of the following basic classes of controlled 
substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)...........................  I
Tetrahydrocannabinols (7370)...............  I
Amphetamine (1100).........................  II
Lisdexamfetamine (1205)....................  II
Methylphenidate (1724).....................  II
Pentobarbital (2270).......................  II
Meperidine (9230)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture bulk controlled substances for use 
in product development and for distribution to its customers.
    In reference to drug code 7360 (Marihuana), the company plans to 
bulk manufacture cannabidiol as a synthetic intermediate. This 
controlled substance will be further synthesized to bulk manufacture a 
synthetic THC (7370). No other activity for this drug code is 
authorized for this registration.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
AMRI Rensselaer, Inc. to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated AMRI Rensselaer, Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance 
with 21 CFR 1301.33, the above named company is granted registration as 
a bulk manufacturer of the basic classes of controlled substances 
listed.

    Dated: May 13, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2011-13204 Filed 5-26-11; 8:45 am]

Read the complete text